Las Vegas, NV -- (SBWIRE) -- 12/06/2012 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume movers as reported by http://beststocksdaily.com/
Peregrine Pharmaceuticals (NASDAQ:PPHM) is currently trading at $1.16, 9.36% lower. Peregrine Pharmaceuticals, Inc. (Peregrine) is a biopharmaceutical company developing monoclonal antibodies for the treatment and diagnosis of cancer. The Company's pipeline of investigational monoclonal antibodies is based on two technology platforms, including PS-targeting antibodies and DNA/histone-targeting antibodies.
Can PPHM Jump Again? Find Out Here http://beststocksdaily.com/p2/index.php?company=PPHM
Sequenom, Inc. (NASDAQ:SQNM) lost 0.64% to $4.66. Sequenom, Inc. (Sequenom) is a molecular diagnostic testing and genetics analysis company committed to providing molecular diagnostic testing services, and research use only products, services, applications, and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock, and other areas of research.
Get Free Trend Analysis on SQNM Here http://beststocksdaily.com/p2/index.php?company=SQNM
CEL-SCI Corporation (NYSE:CVM) is higher 0.31% to $0.288. CEL-SCI Corporation (CEL-SCI) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.
To Get complete technical analysis on CVM go to http://beststocksdaily.com/p2/index.php?company=CVM
VIVUS, Inc. (NASDAQ:VVUS) among the losers and the stock fell 3% to $10.68. VIVUS, Inc. is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutic drugs for underserved markets, including obesity and related morbidities, such as sleep apnea and diabetes, and men's sexual health.
Get Free Trend Analysis on VVUS Here http://beststocksdaily.com/p2/index.php?company=VVUS
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is higher 3.23% to $4.82. ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. The Company has four product candidates in clinical development led by pimavanserin, which is in Phase III development as a first-in-class treatment for Parkinson's disease psychosis.
To Get complete technical analysis on ACAD go to http://beststocksdaily.com/p2/index.php?company=ACAD
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)